Zytoprotec is a clinical stage life sciences company based in Vienna, Austria. The Company's lead product, PD-protec®, is a patent-protected solution for peritoneal dialysis. PD-protec® has moved into a randomized, blinded, multicenter Phase II trial at the end of Q2 2014. Next in Zytoprotec's pipeline is ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. ICO-protec is in preclinical development. Since its inception in 2007, the Company has raised approximately EUR 17 million from its founders, from private investors, and from Austrian and European public agencies.
View Top Employees from Zytoprotec GmbHWebsite | http://zytoprotec.com |
Revenue | $6.3 million |
Employees | 2 (1 on RocketReach) |
Founded | 2007 |
Address | 2-13 Stadiongasse, Vienna, Vienna, AT |
Phone | +43 1 406200220 |
Fax | +43 1 406200220 |
Technologies |
JavaScript,
HTML,
PHP
+3 more
(view full list)
|
Industry | Biotechnology, Research, Hospitals & Clinics, Biopharma, Healthcare, Laboratory Services (Healthcare), Health Care, Science and Engineering, Medical |
SIC | SIC Code 80 Companies, SIC Code 809 Companies |
NAICS | NAICS Code 62149 Companies, NAICS Code 621492 Companies, NAICS Code 6214 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Zytoprotec GmbH employee's phone or email?
The Zytoprotec GmbH annual revenue was $6.3 million in 2024.
Bernhard Zinner is the Managing Director of Zytoprotec GmbH.
1 people are employed at Zytoprotec GmbH.
Zytoprotec GmbH is based in Vienna, Vienna.
The NAICS codes for Zytoprotec GmbH are [62149, 621492, 6214, 621, 62].
The SIC codes for Zytoprotec GmbH are [80, 809].